Every 40 seconds, someone in the United States has a heart attack. Most survive, but at a cost. In the aftermath, the heart cells often stiffen in a process called myocardial fibrosis, a hidden ...

Share on Pinterest A common heart attack pill may not be helpful for some heart conditions, according to new research. Bibek Raj Giri/Getty Images Beta-blockers are a type of medication used after ...

A drug commonly prescribed after a heart attack doesn’t seem to offer significant benefits for people who recover without lasting damage — and could pose added risks to women. In a new research trial, ...

Imagine someone you care about suddenly experiencing chest pain, turning pale, and breathing heavily. These are some of the symptoms of a heart attack. Cardiovascular diseases (CVDs) are the leading ...

Beta blockers—drugs commonly prescribed after a heart attack—may not actually help a large number of patients. This is the "breakthrough" claim of researchers who report that the medicines provide no ...

Beta-blockers have many uses, but they might be outdated as a post-heart attack treatment, new research shows. © Peter de Kievith via Shutterstock A common treatment ...

Chest pain and shortness of breath are two symptoms that grab your attention quickly, potentially signaling a heart attack if they come on suddenly. And if they develop gradually and worsen over time, ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

UNDATED (WKRC/CNN Newsource) - Recent research indicates that beta blockers, long used as a first-line treatment after heart attacks, may not benefit the majority of patients and could even increase ...

NEW YORK CITY — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn't benefit the vast majority of patients and may contribute to a higher ...

Beta blockers, used for decades after heart attacks, provide no benefit for patients with preserved heart function, according to the REBOOT trial. The massive study also found women faced higher risks ...

(CNN) — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...